Skip to main content
. Author manuscript; available in PMC: 2026 Feb 12.
Published in final edited form as: Drug Deliv Transl Res. 2025 Aug 5;16(2):693–710. doi: 10.1007/s13346-025-01920-x

Fig. 2.

Fig. 2

PD-L1 knockdown in different tumors post treatment with PDL E. A) MDA-MB-231 DOX RT cells. B) MDA-MB-231 DOX RT xenograft tumors. C) H1975 OSM RT xenograft tumors. D) MIA PACA 2 cells